http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DK-1824504-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2901e694724c2a759f619944cb7d2a4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-179
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
filingDate 2005-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2009-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bdebbd9e2c1644d46ce134495a0f095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a8d75c4e66e01f3663f7b304512dc09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c45e6b8bb7dd54f6fa3ba1961891d01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48f77c94b2beeeb5d999a5bf153492f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ab20677a846458d0bab335f4568a8e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_921871fe48886fee965baf33db9b600e
publicationDate 2009-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DK-1824504-T3
titleOfInvention Anti-tumor combinations containing VEGF trap and 5-fluorouracil or a derivative thereof
abstract This invention relates to antitumor combinations comprising a VEGF inhibitor combined with 5-fluorouracil or with a 5-fluoropyrimidine derivative that are therapeutically useful in the treatment of neoplastic diseases, and pharmaceutical compositions comprising such combinations.
priorityDate 2004-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415743328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69605

Total number of triples: 36.